Congress Asset Management CO Emergent Bio Solutions Inc. Transaction History

Congress Asset Management CO

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 10, 2020	SELL	$51.21 - $59.06 $3.27 Million - $3.77 Million	-63,813 Closed	0 $0
Q3 2019 Nov 01, 2019	BUY	$40.6 - $57.2 $136,131 - $191,791	3,353 Added 5.55%	63,813 $3.34 Million
Q2 2019 Aug 07, 2019	SELL	$39.92 - $53.86 $506,904 - $683,914	-12,698 Reduced 17.36%	60,460 $2.92 Million
Q1 2019 May 08, 2019	SELL	$48.23 - $66.16 $82,714 - $113,464	-1,715 Reduced 2.29%	73,158 $3.7 Million
Q4 2018 Jan 25, 2019	SELL	$55.63 - $73.24 $458,836 - $604,083	-8,248 Reduced 9.92%	74,873 $4.44 Million
Q3 2018 Oct 26, 2018	SELL	$52.05 - $66.51 $253,015 - $323,305	-4,861 Reduced 5.52%	83,121 $5.47 Million
Q2 2018 Jul 25, 2018	BUY	$48.33 - $55.64 $157,120 - $180,885	3,251 Added 3.84%	87,982 $4.44 Million
Q1 2018 May 11, 2018	BUY	$44.44 - $54.39 $1.03 Million - $1.26 Million	23,168 Added 37.63%	84,731 $4.46 Million
Q4 2017 Jan 30, 2018	BUY	$37.77 - $47.75 $132,459 - $167,459	3,507 Added 6.04%	61,563 $2.86 Million
Q3 2017 Oct 17, 2017	BUY	$34.14 - $40.45 $1.98 Million - $2.35 Million	58,056	58,056 $2.35 Million

160

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $438M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Congress Asset Management CO , based on Form 13F filings with the SEC.

Stay updated on Congress Asset Management CO with notifications on news.